NIH-funded research R01 grant

Understanding the molecular changes in brain cells affected by ALS

Official title: Molecular Phenotyping of Cortical Cell Types in ALS-Related Neurodegeneration

Funded at Rockefeller University · NIH-11080200 · Data updated 2026-11-12

This study is looking at how ALS affects different brain cells to understand why some neurons are more likely to break down, and it hopes to find new treatments that could help people with ALS, so patients can help by sharing samples or taking part in related activities.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRockefeller University
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$423,750
NIH project number5R01NS129902-03
Project IDNIH-11080200 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with ALS who are willing to participate in biological sampling and assessments.

Less likely to help

Patients with other neurodegenerative diseases or those who do not have a diagnosis of ALS may not benefit from this research.

What this research studies

This research investigates the specific molecular changes in different types of brain cells that are affected by amyotrophic lateral sclerosis (ALS). By analyzing gene expression and identifying unique pathways in these cells, the study aims to uncover why certain neurons are more vulnerable to degeneration in ALS. The approach involves advanced techniques to distinguish between similar neuron types, which could lead to targeted therapies. Patients may contribute by providing biological samples or participating in related assessments.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective therapies that halt or reverse the progression of ALS.

How similar studies have gone: Previous research has shown promise in understanding neurodegeneration through molecular profiling, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Rockefeller University
    New York, United States
    Active

Researchers

  • Principal investigator: Schmidt, Eric F — Rockefeller University
  • Study coordinator: Schmidt, Eric F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.